Antiphospholipid syndrome and valvular heart disease, a complex scenario of thrombotic events, a case report.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: BioMed Central Country of Publication: England NLM ID: 101265113 Publication Model: Electronic Cited Medium: Internet ISSN: 1749-8090 (Electronic) Linking ISSN: 17498090 NLM ISO Abbreviation: J Cardiothorac Surg Subsets: MEDLINE
    • Publication Information:
      Original Publication: [London] : BioMed Central, 2006-
    • Subject Terms:
    • Abstract:
      Background: Antiphospholipid syndrome (APS) is a rare coagulation disorder associated with thrombotic events, myocardial infarction, and valvular heart disease. During valvular replacement surgery, the high risk of thrombosis combined with the operative risks in these specific groups of patients poses a challenge to the medical team.
      Case Presentation: We present a case of a female patient with APS and mixed aortic valve disease. During surgery, she suddenly developed complete cardiac arrest. Three months later, after she recovered, and while she was still on close follow up, a thrombotic event caused myocardial infarction. After prompt and precise treatment, the patient successfully recovered; one year after surgery patient is doing well.
      Conclusion: Adequate surgical technique along with optimal anticoagulation strategies and long term follow up are of paramount importance to ensure an uneventful recovery. A multidisciplinary team is required to manage these complex scenarios and high-risk patients.
    • References:
      Anaesth Intensive Care. 2010 Mar;38(2):364-9. (PMID: 20369774)
      N Engl J Med. 2020 Jan 9;382(2):111-119. (PMID: 31733181)
      Circulation. 1985 Oct;72(4):753-67. (PMID: 4028376)
      Ann Thorac Surg. 1965 Jan;1:4-24. (PMID: 14287902)
      Thromb Res. 2017 Mar;151 Suppl 1:S43-S47. (PMID: 28262233)
      Radiology. 1979 Jan;130(1):113-6. (PMID: 758638)
      J Card Surg. 2017 Oct;32(10):633-635. (PMID: 28944492)
      Diagn Pathol. 2011 Aug 02;6:72. (PMID: 21810231)
      Cardiology. 2012;122(2):76-82. (PMID: 22722386)
      Cardiol Res. 2018 Apr;9(2):129-132. (PMID: 29755633)
      Medicine (Baltimore). 2018 Dec;97(51):e13613. (PMID: 30572471)
      Asian Cardiovasc Thorac Ann. 2015 Jun;23(5):535-42. (PMID: 25698796)
      J Cardiol Cases. 2011 Jul 27;4(2):e80-e86. (PMID: 30532875)
      Heart. 2001 Dec;86(6):715-21. (PMID: 11711480)
      Eur J Cardiothorac Surg. 2010 Jan;37(1):154-8. (PMID: 19699100)
      Curr Rheumatol Rep. 2013 Apr;15(4):320. (PMID: 23456852)
      Lupus. 2005;14(9):691-6. (PMID: 16218469)
      S Afr Med J. 1971 Jul 24;45(29):805-9. (PMID: 4255357)
      Arch Surg. 1981 Apr;116(4):480-1. (PMID: 7213008)
      Cleve Clin J Med. 2016 Apr;83(4):271-80. (PMID: 27055201)
      J Med Case Rep. 2013 Sep 10;7:223. (PMID: 24228906)
      Cardiovasc Pathol. 2019 Jul - Aug;41:8-10. (PMID: 31004934)
      J Vasc Surg. 2002 Dec;36(6):1161-6. (PMID: 12469047)
    • Contributed Indexing:
      Keywords: Antiphospholipid syndrome; Aortic valve replacement; Coronaries arteries; Thrombus
    • Accession Number:
      0 (Anticoagulants)
    • Publication Date:
      Date Created: 20200930 Date Completed: 20210226 Latest Revision: 20240802
    • Publication Date:
      20240802
    • Accession Number:
      PMC7526220
    • Accession Number:
      10.1186/s13019-020-01330-9
    • Accession Number:
      32993710